Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

The National Institutes of Health (NIH) is soliciting applications for the Blueprint MedTech Translator program, which aims to support the development of cutting-edge medical devices to prevent, monitor, diagnose, and treat disorders of the nervous or neuromuscular systems. The program will provide non-dilutive funds and additional resources and support services to investigators developing innovative medical device technologies. Key aspects of the program include: * Support for translational activities and clinical studies * Focus on disorders of the nervous or neuromuscular systems * Non-dilutive funds for medical device development activities * Additional resources and support services for investigators * Goal of accelerating patient access to groundbreaking, safe, and effective medical devices * Estimated project duration of 2-3 years * Submission deadline of January 28, 2028 * Anticipated award date of July 1, 2026